Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB384040

IRF3 Antibody (PCRP-IRF3-1E6), DyLight 488, Novus Biologicals™
SDP

Catalog No. NB384040 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB384040 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB384040 Supplier Novus Biologicals Supplier No. NBP308854G
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

IRF3 Monoclonal antibody specifically detects IRF3 in Human samples. It is validated for Western Blot, Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Protein Array

Specifications

Antigen IRF3
Applications Western Blot, Flow Cytometry, Immunofluorescence, Protein Array
Classification Monoclonal
Clone PCRP-IRF3-1E6
Conjugate DyLight 488
Formulation 50mM Sodium Borate
Gene Alias interferon regulatory factor 3, IRF-3
Host Species Mouse
Immunogen Recombinant full-length human IRF3 protein (Uniprot: Q14653)
Purification Method Protein A or G purified
Quantity 100 μg
Regulatory Status RUO
Research Discipline Immunology, Innate Immunity, Transcription Factors and Regulators
Primary or Secondary Primary
Gene ID (Entrez) 3661
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG2a
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.